However, in a study by Blanc-Durand et al., a significantly higher expression of TIM3 (76%) was observed compared to PD-L1 (28%) on ovarian cancer tumor samples of 90 and 173 patients, respectively. The gene discussed is HAVCR2; the disease is ovarian cancer.